Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1967 6
1968 10
1969 6
1970 2
1971 2
1972 2
1973 2
1974 1
1976 1
1980 2
1981 1
1982 2
1983 1
1984 2
1985 2
1987 1
1988 2
1989 3
1990 8
1991 2
1992 4
1994 4
1995 2
1996 4
1997 1
1998 2
1999 5
2000 3
2001 6
2002 9
2003 11
2004 6
2005 13
2006 15
2007 49
2008 59
2009 58
2010 75
2011 105
2012 120
2013 114
2014 97
2015 73
2016 76
2017 77
2018 75
2019 61
2020 54
2021 33
2022 24
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

1,139 results

Results by year

Filters applied: . Clear all
Page 1
Aliskiren.
Anderson DL. Anderson DL. Drugs Today (Barc). 2007 Dec;43(12):849-55. doi: 10.1358/dot.2007.43.12.977448. Drugs Today (Barc). 2007. PMID: 18174970 Review.
Fumaric acid esters.
Rostami Yazdi M, Mrowietz U. Rostami Yazdi M, et al. Clin Dermatol. 2008 Sep-Oct;26(5):522-6. doi: 10.1016/j.clindermatol.2008.07.001. Clin Dermatol. 2008. PMID: 18755371 Review.
Renin inhibitors.
Fisher ND, Meagher EA. Fisher ND, et al. J Clin Hypertens (Greenwich). 2011 Sep;13(9):662-6. doi: 10.1111/j.1751-7176.2011.00514.x. Epub 2011 Jul 27. J Clin Hypertens (Greenwich). 2011. PMID: 21896147 Free PMC article. Review.
Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study.
Naismith RT, Wundes A, Ziemssen T, Jasinska E, Freedman MS, Lembo AJ, Selmaj K, Bidollari I, Chen H, Hanna J, Leigh-Pemberton R, Lopez-Bresnahan M, Lyons J, Miller C, Rezendes D, Wolinsky JS; EVOLVE-MS-2 Study Group. Naismith RT, et al. CNS Drugs. 2020 Feb;34(2):185-196. doi: 10.1007/s40263-020-00700-0. CNS Drugs. 2020. PMID: 31953790 Free PMC article. Clinical Trial.
Aliskiren (Speedel).
Allikmets K. Allikmets K. Curr Opin Investig Drugs. 2002 Oct;3(10):1479-82. Curr Opin Investig Drugs. 2002. PMID: 12431022 Review.
Diroximel fumarate to treat multiple sclerosis.
Wang Y, Bhargava P. Wang Y, et al. Drugs Today (Barc). 2020 Jul;56(7):431-437. doi: 10.1358/dot.2020.56.7.3151521. Drugs Today (Barc). 2020. PMID: 32648853 Review.
Dimethyl fumarate-associated ashy dermatosis.
Burlando M, Salvi I, Guadagno A, Cozzani E, Parodi A. Burlando M, et al. J Dtsch Dermatol Ges. 2022 Nov;20(11):1502-1504. doi: 10.1111/ddg.14889. Epub 2022 Nov 10. J Dtsch Dermatol Ges. 2022. PMID: 36354064 No abstract available.
1,139 results